New nucleoside analogues in clinical development.
Faderl
Stefan
S
Department of Leukemia, University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA.
Gandhi
Varsha
V
Kantarjian
Hagop
H
Plunkett
William
W
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D019384:Nucleic Acid Synthesis Inhibitors; D009705:Nucleosides / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D019384:Nucleic Acid Synthesis Inhibitors; D009705:Nucleosides; D012321:DNA-Directed RNA Polymerases